|
|
|
| Discussion on paracentral acute middle maculopathy from “collateral theory” |
| SUN Mei1,2 HAO Xiaofeng2 XIE Like2 JIN Qi1,2 |
1.China Academy of Chinese Medical Sciences, Beijing 100700, China;
2.Surgical Department of Ocular Fundus Disease, Eye Hospital of China Academy of Chinese Medical Sciences, Beijing 100040, China |
|
|
|
Abstract Paracentral acute middle maculopathy (PAMM) is a rare disease caused by ischemia of the middle and deep capillaries of the retina. Retinal blood vessels are tiny, belonging to collaterals, collaterals and eyes have a close relationship. This article discusses the relationship between the collaterals and the PAMM through the elaboration of the relationship between the collaterals and the eyes physiology and pathology, starting with the collateral theory. Deficiency of positive qi is the basis of PAMM, and eye collaterals stasis is the core of PAMM. PAMM pathogenes is features are comprised of being easy to block and choke, easy to enter but difficult to come out, and easy to form a visible lesion. In clinical practice, we should pay attention to the use of pungent drugs, insect drugs, rattan drugs and tonic drugs, treat both manifestation and root cause of disease, strengthen vital qi to eliminate pathogenic factor in the treatment of PAMM.
|
|
|
|
|
|
[1] Sarraf D，Rahimy E，Fawzi AA，et al. Paracentral acute middle maculopathy：a new variant of acute macular neuroretinopathy associated with retinal capillary ischemia [J]. JAMA Ophthalmol，2013，131（10）：1275-1287.
[2] Ang MJ，Chen JJ，McDonald HR. Paracentral acute middle maculopathy after epiretinal membrane removal [J]. Retin Cases Brief Rep，2019. [Online ahead of print].
[3] Maltsev DS，Kulikov AN，Burnasheva MA，et al. Prevalence of resolved paracentral acute middle maculopathy lesions in fellow eyes of patients with unilateral retinal vein occlusion [J]. Acta Ophthalmol，2020，98（1）：e22-e28.
[4] 蒋莉，罗小玲，邓铤明，等.急性黄斑旁中心中层视网膜病变一例[J].中华眼底病杂志，2020，36（4）：312-313.
[5] 陶有青，杨传华.络脉-络病理论溯源及现代发展概况[J].安徽中医学院学报，2010，29（5）：6-9.
[6] 萧淑芳.络脉学说源流及理论前景[J].中国中医基础医学杂志，2007，13（3）：177.
[7] 徐宗佩，张伯礼，高秀梅，等.久病入络患者瘀血证与微循环障碍相关性研究[J].陕西中医，1997，18（9）：423-425.
[8] 王永炎，常富业，杨宝琴.络脉与络病对比研究[J].北京中医药大学学报，2005，28（3）：1-6.
[9] 吴以岭.脉络学说构建及其指导血管病变防治研究[C]//中华中医药学会血栓病分会第七次学术研讨会暨河北省中医药学会健康营养药膳专业委员会学术会议论文集，2013.
[10] 唐容川.血证论[M].北京：学苑出版社，2012：47.
[11] 吴以岭.络病病机探析[J].中医杂志，2005，46（4）：243-245.
[12] 周伟，胡兴兴，韩梅，等.高血压性视网膜病变合并继发性急性黄斑旁中心中层视网膜病变一例[J].中华眼底病杂志，2019，35（2）：192-193.
[13] Sebastiani S，Pellegrini M，Giannaccare G，et al. Paracentral acute middle maculopathy associated with phosphodiesterase-5 inhibitor therapy [J]. Retin Cases Brief Rep，2018. [Online ahead of print].
[14] da Fonseca MLG，Souza A，Pereira MB，et al. Paracentral acute middle maculopathy associated with hypoperfusion of the cilioretinal artery and impending central retinal vein occlusion [J]. Eur J Ophthalmol，2019: 1120672119 885787. [Online ahead of print].
[15] Schofield JR，Palestine AG，Pelak V，et al. Deep capillary retinal ischemia and high-titer prothrombin-associated antiphospholipid antibodies：a case series of three patients [J]. Am J Ophthalmol Case Rep，2019，14：105-109.
[16] Pham C，Boo A，Chew SKH，et al. Paracentral acute middle maculopathy in a young patient following routine phacoemulsification surgery [J]. Clin Exp Ophthalmol,2019，47（9）：1206-1209.
[17] 张铭连，杨赞章.基于目络学说对缺血性眼病病机和治疗的再认识[J].中国中医眼科杂志，2020，30（2）：85-88.
[18] 杨赞章，张越，张铭连.基于络病理论探讨缺血性眼病的病机[J].中国中医眼科杂志，2017，27（6）：389-391.
[19] 王江平，沈晓峰.《临证指南医案》治疗络病的用药规律分析[J].临床医药文献电子杂志，2018，5（17）：81-82.
[20] 王志立，陈晓，柳慧，等.急性黄斑旁中心中层视网膜病变临床特征[J].中华实验眼科杂志，2019，37（1）：16-20.
[21] 郭承伟，吕璐.《内经》络脉理论与眼科应用探讨[J].中国中医眼科杂志，2010，20（4）：237-239.
[22] 李晓宇，谢立科，郝晓凤，等.谢立科从“高巅之上，惟风可到”论治眼病经验探析[J].中国中医眼科杂志，2018， 28（2）：112-116.
[23] 刘雪，詹宇坚，郭霞.浅谈辛味药在眼科临床中的运用[J].新中医，2008，40（9）：103.
[24] 李世迎，赵晨，张敏芳，等.急性黄斑旁中心中层视网膜病变二例[J].中华眼底病杂志，2017，33（6）：642-643.
[25] 郝晓凤，谢立科，李晓宇，等.谢立科“祛积通络法”治疗视网膜静脉阻塞经验[J].中国中医眼科杂志，2017，27（4）：232-235. |
|
|
|
